Sintx Technologies (SINT) Gains from Sales and Divestitures (2014 - 2026)

Sintx Technologies (SINT) recorded quarterly Gains from Sales and Divestitures of $42.0 million in Q1 2026, up 1158.96% quarter-over-quarter from $3.3 million in Q1 2025, and up 1158.96% on a YoY basis from $3.3 million in Q1 2025.

Sintx Technologies (SINT) Gains from Sales and Divestitures (2014 - 2026) Analysis & Trends

Sintx Technologies' Gains from Sales and Divestitures history runs 4 years deep, the most recent figure standing at $42.0 million for Q1 2026.

  • In Q1 2026, Gains from Sales and Divestitures rose 1158.96% year-over-year to $42.0 million; the TTM figure through Mar 2026 stood at $42.0 million (up 1158.96% YoY), while the FY2015 annual figure was $18000.0, down 98.91% from the prior year.
  • Gains from Sales and Divestitures was $42.0 million for Q1 2026 at Sintx Technologies, up from $3.3 million in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $42.0 million in Q1 2026 to a low of $3.3 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Sintx Technologies 8.79 Mn 6.90 Mn 144,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 42.00 Mn
Mar 31, 2026 42.00 Mn
Mar 31, 2025 3.34 Mn
Mar 31, 2025 3.34 Mn
Dec 31, 2015 18,000.00
Dec 31, 2015 18,000.00
Dec 31, 2014 1.65 Mn
Dec 31, 2014 1.65 Mn
Sep 30, 2014 506,272.00
Sep 30, 2014 506,272.00
Jun 30, 2014 38,798.00
Jun 30, 2014 38,798.00
Mar 31, 2014 38,798.00
Mar 31, 2014 38,798.00